






















![]()
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Q1 2026 Earnings Call May 6, 2026 5:00 AM EDT
Company Participants
Marta Campos Martinez - Head of Investor Relations
Juan Encina - Chairman & CEO
Javier López-Belmonte Encina - First Deputy Chairman, GM of Industrial Operations & CFO
Presentation
Marta Campos Martinez
Head of Investor Relations
Hello, everyone. This is Marta Campos, Head of Finance for ROVI. Welcome to our company's review of business results for the first quarter of 2026.
Before we begin, let me remind you that today's presentation and associated documentation are available on the Investor Relations section of ROVI's website. Please note that the information presented in this call contains forward-looking statements based on our current beliefs and expectations. Actual results could materially differ due to known and unknown risks, uncertainties and other factors, and we undertake no obligation to update or revise any of the statements.
Moving to today's agenda. Juan Lopez-Belmonte, ROVI's Chairman and Chief Executive Officer, will discuss our business performance for the quarter. Javier Lopez-Belmonte, ROVI's Deputy Chairman and Chief Financial Officer, will then review financial results. The presentation will be followed by a Q&A session. Therefore, if you want to ask any questions during the presentation, please do not hesitate to send them through the question button on the platform.
With that, I thank you for your presence here today, and will now turn the call over to Juan.
Juan Encina
Chairman & CEO
Thank you, Marta, and thanks to everyone for joining us today. Let me start by addressing our outlook for 2026. In light of recent developments and greater visibility in key business drivers, we have revised our expectations for the full year. I will provide the strategic context and Javier will then take you through the detailed financials.
Let me continue what we have
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。